223 employees
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
2015
$200M
from 1 investors over 1 rounds
Kiniksa Pharmaceuticals raised $200M on February 1, 2018
Investors: Sofinnova Ventures, Russia technology fund